Form 4: U.S. Physical Therapy Director Clayton Trier Reports Sale of Shares
SEC Form 4
Director Clayton Trier reported selling 400 shares of U.S. Physical Therapy Inc. at $107 per share on March 13, 2024.
Summary
- On March 13, 2024, Clayton Trier, a director of U.S. Physical Therapy Inc., sold 400 shares of common stock at a price of $107 per share.
- Following the transaction, Trier still beneficially owns 7,000 shares, which includes 400 shares of restricted stock granted under the company's equity plans.
- The restrictions on these 400 shares will lapse on April 1, 2024, contingent upon Trier's continued service as a director.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing reporting a director's stock sale. It doesn't inherently convey positive or negative sentiment.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This sale represents a small percentage of the director's holdings.
Stakeholder Impact
- The sale of shares by a director could be perceived neutrally or slightly negatively by shareholders, depending on the context and reasons for the sale.
Key Dates
| Date | Description |
|---|---|
| 03/13/2024 | Date of transaction: Clayton Trier sold 400 shares of USPH stock. |
| 03/14/2024 | Date of signature on the Form 4 filing. |
| 04/01/2024 | Restrictions on 400 shares of restricted stock lapse, subject to continued service as director. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.